Hepatitis viruses: genetic variants and clinical significance

  • H. E. Blum
Review

Abstract

Variants of hepatitis B, C, and delta virus have been identified in patients both with acute and chronic infections. In the hepatitis B virus genome, naturally occurring mutations have been found in all viral genes, most notably in the genes coding for the structural envelope and nucleocapsid proteins. In the hepatitis C virus genome, the regions coding for the structural envelope proteins El and E2, as well as the 3′-contiguous non-structural regionNS1, were found to be hypervariable. Viral variants may be associated with a specific clinical course of the infection, e.g., acute, fulminant or chronic hepatitis. Specific mutations may reduce viral clearance by immune mechanisms (‘vaccine escape’ and ‘immune escape’), response to antiviral therapy (‘therapy escape’), as well as detection (‘diagnosis escape’). The exact contribution, however, of specific mutations to the pathogenesis and natural course of hepatitis B, C, or delta virus infection, including hepatocellular carcinoma development, and the response to antiviral treatment remains to be established.

Key words

Hepatitis viruses Variants Genotypes Mutants Quasi-species 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325:1325.PubMedGoogle Scholar
  2. 2.
    Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, Gitnick G. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993; 17:361.PubMedGoogle Scholar
  3. 3.
    Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991;325:454.PubMedGoogle Scholar
  4. 4.
    Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, Wilber JC, Levey AS. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327:910.PubMedGoogle Scholar
  5. 5.
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899.PubMedGoogle Scholar
  6. 6.
    Roudot-Thoraval F, Pawlotsky JM, Thiers V, Deforges L, Girollet PP, Guillot F, Huraux C, Aumont P, Brechot C, Dhumeaux D. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology 1993; 17:772.PubMedGoogle Scholar
  7. 7.
    Thaler MM, Park CK, Landers DV, Wara DW, Houghton M, Veereman Wauters G, Sweet RL, Han JH. Vertical transmission of hepatitis C virus. 1991; 338: 17.Google Scholar
  8. 8.
    Reinus JF, Leikin EL, Alter HJ, Cheung L, Shindo M, Jett B, Piazza S, Shih JW. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 1992; 117:881.PubMedGoogle Scholar
  9. 9.
    Wejstal R, Widell A, Mansson AS, Hermodsson S, Norkrans G. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 1992; 117:887.PubMedGoogle Scholar
  10. 10.
    Bresters D, Mauser Bunschoten EP, Reesink HW, Roosendaal G, Poel CL van der, Chamuleau RA, Jansen PL, Weegink CJ, Cuypers HT, Lelie PN, et al. Sexual transmission of hepatitis C virus. Lancet 1993; 342:210.PubMedCrossRefGoogle Scholar
  11. 11.
    Alter MJ. Inapparent transmission of hepatitis C: footprints in the sand (editorial). Hepatology 1991; 14:389.PubMedGoogle Scholar
  12. 12.
    Ridzon R, Gallagher K, Ciesielski C, Mast EE, Ginsberg MB, Robertson BJ, Luo C-C, DeMaria A Jr. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury. N Engl J Med 1997; 3:919.CrossRefGoogle Scholar
  13. 13.
    Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335.PubMedGoogle Scholar
  14. 14.
    Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1978; 75:4533.PubMedCrossRefGoogle Scholar
  15. 15.
    Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 1980; 77:2941.PubMedCrossRefGoogle Scholar
  16. 16.
    Mason WS, Seal G, Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 1980; 36:829.PubMedGoogle Scholar
  17. 17.
    Sprengel R, Kaleta EF, Will H. Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 1988; 62: 3832.PubMedGoogle Scholar
  18. 18.
    Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993; 361:742.PubMedCrossRefGoogle Scholar
  19. 19.
    Medina T de, Haviv I, Noiman S, Shaul Y. The X protein of hepatitis B virus has a ribo/deoxy ATPase activity. Virology 1994; 202:401.CrossRefGoogle Scholar
  20. 20.
    Huang J, Kwong J, Sun EC-Y, Liang TJ. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol 1996:70:5582.PubMedGoogle Scholar
  21. 21.
    Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 1993; 342:1340.PubMedCrossRefGoogle Scholar
  22. 22.
    Chiagn PW, Jeng KS, Hu CP, Chang CM. Characterization of acis element required for packaging and replication of the human hepatitis B virus. Virology 1992; 186:701.CrossRefGoogle Scholar
  23. 23.
    Huang J, Liang T. A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 1993; 13:7476.PubMedGoogle Scholar
  24. 24.
    Tavis JE, Perri S, Ganem D. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J Virol 1994; 68: 3536.PubMedGoogle Scholar
  25. 25.
    Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982:29:403.PubMedCrossRefGoogle Scholar
  26. 26.
    Wang GH, Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 1993; 67:6507.PubMedGoogle Scholar
  27. 27.
    Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol 1994:68:6.PubMedGoogle Scholar
  28. 28.
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359.PubMedCrossRefGoogle Scholar
  29. 29.
    Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology 1997; 25: 1527.PubMedCrossRefGoogle Scholar
  30. 30.
    Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology 1991; 14:381.PubMedGoogle Scholar
  31. 31.
    Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277: 570.PubMedCrossRefGoogle Scholar
  32. 32.
    Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 1997; 94: 8738.PubMedCrossRefGoogle Scholar
  33. 33.
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244:362.PubMedCrossRefGoogle Scholar
  34. 34.
    Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501.PubMedCrossRefGoogle Scholar
  35. 35.
    Zaaijer H, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341:722.PubMedCrossRefGoogle Scholar
  36. 36.
    Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH. Niesters HGM, Lelie PN. International collaborative study on the second EUROHEP HCV-RNA reference panel. J Virol Methods 1996; 58: 175.PubMedCrossRefGoogle Scholar
  37. 37.
    Pawlotsky J-M. Measuring hepatitis C viremia in clinical samples: can we trust the assays? Hepatology 1997; 26: 1.PubMedCrossRefGoogle Scholar
  38. 38.
    Tanaka E, Kiyosawa K, Ivlatsumoto A. Kashiwakuma T, Hasegawa A, Mori H, Yanagihara O, Ohta Y. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alpha. Hepatology 1996; 23:1330.PubMedCrossRefGoogle Scholar
  39. 39.
    Rizzetto M. The delta agent. Hepatology 1983; 3:729.PubMedCrossRefGoogle Scholar
  40. 40.
    Taylor J. Hepatitis delta virus. J Hepatol 1991; 13 [Suppl 4]: S114.PubMedCrossRefGoogle Scholar
  41. 41.
    Polish LB, Gallagher M, Fields HA, Hadler SC. Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 1993; 6: 211.PubMedGoogle Scholar
  42. 42.
    Domingo E, Sabo D, Taniguchi T, Weissmann C. Nucleotide sequence heterogeneity of a RNA phase population. Cell 1978; 13:735.PubMedCrossRefGoogle Scholar
  43. 43.
    Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341:349.PubMedCrossRefGoogle Scholar
  44. 44.
    Blum HE, Liang TJ, Galun E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14:56.PubMedCrossRefGoogle Scholar
  45. 45.
    Hasegawa K, Huang J, Rogers SA, Blum HE, Liang TJ. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994; 68:1651.PubMedGoogle Scholar
  46. 46.
    Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology 1989; 170:595.PubMedCrossRefGoogle Scholar
  47. 47.
    Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325.PubMedCrossRefGoogle Scholar
  48. 48.
    Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckermann AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 1991; 13 [Suppl 4]: S105.PubMedCrossRefGoogle Scholar
  49. 49.
    Waters JA, Kennedy M, Voet P, HÄuser P, Petre J, Carman W, Thomas HC. Loss of the common “a” determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 1992; 90:2543.PubMedCrossRefGoogle Scholar
  50. 50.
    Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakaki Y, Okochi K, Nakajima E. Gly 145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992;184:1152.PubMedCrossRefGoogle Scholar
  51. 51.
    Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S. Mutations within theS gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res 1992; 32:264.PubMedCrossRefGoogle Scholar
  52. 52.
    Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M. Naturally occurring escape mutants of hepatitis B virus with various mutations in theS gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994; 68:2671.PubMedGoogle Scholar
  53. 53.
    Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 1994; 169: 1374.PubMedGoogle Scholar
  54. 54.
    McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PL Ostberg L. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 1992; 15:757.PubMedCrossRefGoogle Scholar
  55. 55.
    Carman WF, Trautwein C, Deursen FJ van, Colman K, Dornan E, Mclntyre G, Waters J, Kliem V, Müller R, Thomas HC, Manns MP. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24:489.PubMedCrossRefGoogle Scholar
  56. 56.
    Gerken G, Kremsdorf D, Capel F, Petit MA, Dauguet C, Manns MP. Meyer zum Bueschenfelde KH, Brechot C. Hepatitis B defective virus with rearrangements in thepre S gene during chronic HBV infection. Virology 1991; 183:555.PubMedCrossRefGoogle Scholar
  57. 57.
    Fernholz D, Galle PR, Stemler M, Brunetto M, Bonino F, Will H. Infectious hepatitis B virus variant defective in pre82 protein expression in a chronic carrier. Virology 1993; 194:137.PubMedCrossRefGoogle Scholar
  58. 58.
    Minami M, Okanoue T, Nakajima E, Yasui K, Kagawa K. Kashima K. Significanceof pre-S region-defective hepatitis B virus that emerged during exacerbation of chronic type B hepatitis. Hepatology 1993; 17:558.PubMedCrossRefGoogle Scholar
  59. 59.
    Melegari M, Bruno S, Wands JR. Properties of hepatitis B viruspre-S 1 deletion mutants. Virology 1994; 199:292.PubMedCrossRefGoogle Scholar
  60. 60.
    Nakajima E, Minami M, Ochiya T, Kagawa K, Okanoue T.Pre S 1 deleted variants of hepatitis B virus in. patients with chronic hepatitis. J Hepatol 1994; 20:329.PubMedCrossRefGoogle Scholar
  61. 61.
    Xu Z, Yen TSB. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol 1996;70:133.PubMedGoogle Scholar
  62. 62.
    Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 1997; 26:495.PubMedCrossRefGoogle Scholar
  63. 63.
    Michalak TI, Pasquinelli C, Guilhot S, Chisari FV Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994:94:230.CrossRefGoogle Scholar
  64. 64.
    Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, Chisari FV, Rehermann B, Del Prete G, Fiaccadori F, Ferrari C. Long-lasting memory T cell responses following selflimited acme hepatitis B. J Clin Invest 1996; 98: 1185.PubMedCrossRefGoogle Scholar
  65. 65.
    Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104.PubMedCrossRefGoogle Scholar
  66. 66.
    Kato J. Hasegawa K, Torii N, Yamauchi K, Hayashi N. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology 1996; 23: 389.PubMedCrossRefGoogle Scholar
  67. 67.
    Caselmann WH, Meyer M, Kekule AS, Lauer U, Hofschneider PH, Koshy R. A trans-activator function is generated by integration of hepatitis B viruspreS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA 1990: 87:2970.PubMedCrossRefGoogle Scholar
  68. 68.
    Lauer U, Weiss L, Lipp M, Hofschneider PH, Kekule AS. The hepatitis B viruspreS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 1994: 19:23.PubMedGoogle Scholar
  69. 69.
    Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; II: 588.CrossRefGoogle Scholar
  70. 70.
    Brunetto MR, Stemler M, Bonino F, Schödel F, Oliveri F, Rizzetto M, Verme G, Will H. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 1990; 10:258.PubMedCrossRefGoogle Scholar
  71. 71.
    Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, Omi S, Okamoto H, Miyakawa Y, Mayumi M. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 1990; 99: 1113.PubMedGoogle Scholar
  72. 72.
    Kosaka Y, Takase K, Kojima M, Shimizu M, Inoue K, Yoshiba M, Tanaka S, Akahane Y, Okamoto H, Tsuda F, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087.PubMedGoogle Scholar
  73. 73.
    Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991 ; 324: 1699.PubMedGoogle Scholar
  74. 74.
    Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705.PubMedGoogle Scholar
  75. 75.
    Naoumov NV, Schneider R, Grotzinger T, Jung MC, Miska S, Pape GR, Will H. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992; 102:538.PubMedGoogle Scholar
  76. 76.
    Okamoto Y, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1298.PubMedGoogle Scholar
  77. 77.
    Omi S, Okamoto H, Tsuda F, Mayumi M. Defects in the precore region of hepatitis B virus DNA in a plasma pool from carriers seropositive for antibody against e antigen and with infectivity in chmpanzees. J Gastroenterol Hepatol 1990; 5: 646.PubMedCrossRefGoogle Scholar
  78. 78.
    Tur Kaspa R, Klein A, Aharonson S. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. Hepatology 1992;16:1338.CrossRefGoogle Scholar
  79. 79.
    Laskus T, Persing DHL Nowicki MJ, Mosley JW, Rakela J. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993; 105:1173.PubMedGoogle Scholar
  80. 80.
    Wakita T, Kakumu S, Shibata M, Yoshioka K, Ito Y, Shinagawa T, Ishikawa T, Takayanagi M, Morishima T. Detection ofpre-C andcore region mutants of hepatitis B virus in chronic hepatitis B virus carriers. J Clin Invest 1991; 88: 1793.PubMedCrossRefGoogle Scholar
  81. 81.
    Ehata J, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codons 84–101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992; 89: 332.PubMedCrossRefGoogle Scholar
  82. 82.
    Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosodam K, Ohto M. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993; 91:1206.PubMedCrossRefGoogle Scholar
  83. 83.
    Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994; 369:407.PubMedCrossRefGoogle Scholar
  84. 84.
    Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99: 1472.PubMedCrossRefGoogle Scholar
  85. 85.
    Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13: 29.PubMedCrossRefGoogle Scholar
  86. 86.
    Karayiannis P, Alexopoulou A, Hadziyannis S, Thursz M, Watts R, Seito S, Thomas CH. Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 1995; 22: 1628.PubMedGoogle Scholar
  87. 87.
    Fang JW, Tung FY, Davis GL, Dolson DJ, Van Thiel DH, Lau JY. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901.PubMedGoogle Scholar
  88. 88.
    McMillan JS, Bowden DS, Angus PW, McCaughan GW, Locarnini SA. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation. Hepatology 1996; 24: 1371.PubMedCrossRefGoogle Scholar
  89. 89.
    Naumann U, Protzer-Knolle U, Berg T, Leder K, Lobeck H, Bechstein W-O, Gerken G, Hopf U, Neuhaus P. A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis. Hepatology 1997; 26:478.PubMedCrossRefGoogle Scholar
  90. 90.
    Chen HS, Kew MC, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol 1992; 66:5682.PubMedGoogle Scholar
  91. 91.
    Chuang WL, Omata M, Ehata T, Yokosuka O, Hosoda K, Imazeki F, Ohto M. Coinfection study of precore mutant and wildtype hepatitis B-like virus in ducklings. Hepatology 1994; 19:569.PubMedCrossRefGoogle Scholar
  92. 92.
    Pastore G, Santantonio T, Milella M. Monno L, Mariano N, Moschetta R, Pollice L. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: response to a 6-month course of lymphoblastoid interferon. J Hepatol 1992; 14:221.PubMedCrossRefGoogle Scholar
  93. 93.
    Santantonio T, Jung MC, Monno L, Milella M, Iacavazzi T, Pape GR, Pastore G, Will H. Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity. Arch Virol 1993; 8: 171.Google Scholar
  94. 94.
    Brunetto MR, Giarin M, Saracco G. Oliveri F, Calvo P, Capra G, Randone A, Abate ML, Manzini P, Capalbo M, et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105:845.PubMedGoogle Scholar
  95. 95.
    Fattovich G, Farci P, Rugge M, Brollo L, Mandas A, Pontisso P, Giustina G, Lai ME, Belussi F, Busatto G, et al. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992;15:584.PubMedCrossRefGoogle Scholar
  96. 96.
    Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91:2230.PubMedCrossRefGoogle Scholar
  97. 97.
    Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester H, Stiirzbecher H-W, Hoeijmakers JHJ. Harris CC. Abrogation of p53-induced apoptosis by the hepatitis B virusx gene. Cancer Res 1995; 55:6012.PubMedGoogle Scholar
  98. 98.
    Lee H, Lee Y-H, Huh Y-S, Moon H, Yun Y. X-gene product antagonizes the p53-mediated inhibition of hepatitis B virus replication through regulation of the pregenomic/core promoter. J Biol Chem 1995; 270: 1405.Google Scholar
  99. 99.
    Lee T-H, Elledge SJ, Butel JS. Hepatitis B virus x protein interacts with a probable cellular DNA repair protein. J Virol 1995; 69:1107.PubMedGoogle Scholar
  100. 100.
    Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA 1995; 92: 11 215.CrossRefGoogle Scholar
  101. 101.
    Blum HE, Zhang ZS, Galun E, WeizsÄcker F von. Garner B, Liang TJ, Wands JR. Hepatitis B virus X protein is not central to the viral life cycle in vitro. J Virol 1992; 66: 1223.PubMedGoogle Scholar
  102. 102.
    Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 1993; 195:305.PubMedCrossRefGoogle Scholar
  103. 103.
    Murakami S, Cheong JH, Kaneko S. Human hepatitis virusX gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 1994; 269: 15 118.Google Scholar
  104. 104.
    Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993; 67: 1218.PubMedGoogle Scholar
  105. 105.
    Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994; 68:2026.PubMedGoogle Scholar
  106. 106.
    Takada S, Koike K. Trans-activation function of a 3′ truncatedX gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 1990; 87:5628.PubMedCrossRefGoogle Scholar
  107. 107.
    Wollersheim M, Debelka U, Hofschneider PH. A trans-activating function encoded in the hepatitis B virusX gene is conserved in the integrated state. Oncogene 1988; 3:545.PubMedGoogle Scholar
  108. 108.
    Loncarevic IF, Zentgraf H, Schröder CH. Sequence of a replication competent hepatitis B virus genome with apreX open reading frame. Nucleic Acids Res 1990; 18:4940.PubMedCrossRefGoogle Scholar
  109. 109.
    Repp R, Keller C, Borkhardt A, Csecke A, Schaefer S, Geriich WH, Lampert F. Detection of a hepatitis B virus variant with a truncatedX gene and enhancer II. Arch Virol 1992; 125:299.PubMedCrossRefGoogle Scholar
  110. 110.
    Kim SH, Hong SP, Kim SK, Lee WS, Rho HM. Replication of a mutant hepatitis B virus with a fusedX-C reading frame in hepatoma cells. J Gen Virol 1992; 73:2421PubMedGoogle Scholar
  111. 111.
    Feitelson MA. Biology of hepatitis B virus variants. Lab Invest 1994; 71:324.PubMedGoogle Scholar
  112. 112.
    Blum HE, Galun E, Liang TJ, WeizsÄcker F von, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 1836.PubMedGoogle Scholar
  113. 113.
    Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24:714.PubMedGoogle Scholar
  114. 114.
    Ling R, Mutimer D, Ahmed M, Boxall EH, Elias E, Dusheiko GM, Harrison TJ. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24:711.PubMedCrossRefGoogle Scholar
  115. 115.
    Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349:20.PubMedCrossRefGoogle Scholar
  116. 116.
    Bain VG, Knetemann NM, Ma MM, Gutfreund K, Shapiro JA, Fischer K, Tipples G, Lee H, Jewell LD, Tyrrell DL. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.PubMedCrossRefGoogle Scholar
  117. 117.
    Aye TT, Bartholomeusz A, Shaw T, Breschkin AM, Gronen L, Bowden DS, McMillan JS, Angus PW, McCaughan GW, Locarnini SA. Hepatitis B virus polymerase mutations during famciclovir therapy in patients following liver transplantation. Hepatology 1996; 24:285A.Google Scholar
  118. 118.
    Günther S, Baginski S, Kissel H, Reinke P, Kriiher DH, Will H, Meisel H. Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end-stase liver disease. Hepatology 1996; 24:751.PubMedCrossRefGoogle Scholar
  119. 119.
    Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka K, Miyakawa Y, Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 1994; 68:8102.PubMedGoogle Scholar
  120. 120.
    Baumert TF, Rogers SA, Hasegawa K, Liang TJ. Two core promoter mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest 1996; 98:2268.PubMedCrossRefGoogle Scholar
  121. 121.
    Laskus T, Rakela J, Steers JL, Wiesner RH, Persing DH. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. Gastroenterology 1994; 107:1774.PubMedGoogle Scholar
  122. 122.
    Pult I, Chouard T, Wieland S, Klemenz R, Yaniv M, Blum HE. A hepatitis B virus mutant with a new hepatocyte nuclear factor binding site emerging in transplant transmitted fulminant hepatitis B. Hepatology 1997; 25: 1507.PubMedCrossRefGoogle Scholar
  123. 123.
    Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putativeE1 gene of isolates collected worldwide. Proc Natl Acad Sci USA 1993;90:8234.PubMedCrossRefGoogle Scholar
  124. 124.
    Okamoto H, Kanai N, Mishiro S. Full-length nucleotide sequence of a Japanese hepatitis C virus isolate (HC-J1) with high homology to USA isolates. Nucleic Acids Res 1992; 20:6410.PubMedCrossRefGoogle Scholar
  125. 125.
    Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73:673.PubMedCrossRefGoogle Scholar
  126. 126.
    Chan CY, Lee SD, Tsai YT, Lo KJ. Long-term follow-up of hepatitis B vaccination in susceptible hospital personnel. J Gastroenterol Hepatol 1992; 7:266.PubMedCrossRefGoogle Scholar
  127. 127.
    Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992; 89:7144.PubMedCrossRefGoogle Scholar
  128. 128.
    Liu K, Hu Z, Li H, Prince AM, Inchauspe G. Genomic typing of hepatitis C viruses present in China. Gene 1992: 114:245.PubMedCrossRefGoogle Scholar
  129. 129.
    Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina Selby R, Barr PJ, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88:2451.PubMedCrossRefGoogle Scholar
  130. 130.
    Brechot C, Kremsdorf D. Genetic variation of the hepatitis C virus (HCV) genome: random events or a clinically relevant issue? J Hepatol 1993; 17:265.PubMedCrossRefGoogle Scholar
  131. 131.
    Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321.PubMedGoogle Scholar
  132. 132.
    Dusheiko G, Simmonds P. Sequence variability of hepatitis C virus and its clinical relevance. J Viral Hepatitis 1994; 1: 3.CrossRefGoogle Scholar
  133. 133.
    Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA 1992; 89:4942.PubMedCrossRefGoogle Scholar
  134. 134.
    Lee CH, Cheng C, Wang J, Lumeng L. Identification of hepatitis C viruses with a nonconserved sequence of the 5′ untranslated region. J Clin Microbiol 1992; 30: 1602.PubMedGoogle Scholar
  135. 135.
    Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3392.PubMedCrossRefGoogle Scholar
  136. 136.
    Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P, Kurimura T, Shimotohno K. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 1992; 183:334.PubMedCrossRefGoogle Scholar
  137. 137.
    Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes (published erratum appears in J Hepatol 1992; 14:435). J Hepatol 1992; 14:35.PubMedCrossRefGoogle Scholar
  138. 138.
    Dusheiko G, Schmilovitz Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, Mclntyre N, Simmonds P. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994; 19:13.PubMedGoogle Scholar
  139. 139.
    Kato N, Ootsuyama Y, Tanaka T, Nakagawa M, Nakazawa T, Muraiso K, Ohkoshi S, Hijikata M, Shimotohno K. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res 1992; 22: 107.PubMedCrossRefGoogle Scholar
  140. 140.
    Murakawa K, Esumi M, Kato T, Kambara H, Shikata T. Heterogeneity within the nonstructural protein 5′-encoding region of hepatitis C viruses from a single patient. Gene 1992: 117:229.PubMedCrossRefGoogle Scholar
  141. 141.
    Tanaka T, Kato N, Nakagawa M, Ootsuyama Y, Cho MJ, Nakazawa T, Hijikata M, Ishimura Y, Shimotohno K. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: sequence variation within the same individual and among infected individuals. Virus Res 1992; 23: 39.PubMedCrossRefGoogle Scholar
  142. 142.
    Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, Kaneko S, Unoura M, Kobayashi K. Severity of liver disease with different hepatitis C viral clones (Letter), Lancet 1991; 338:509.PubMedCrossRefGoogle Scholar
  143. 143.
    Mihm S, Fayyazi A, Hartmann H, Ramadori G. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 1997; 25:735.PubMedCrossRefGoogle Scholar
  144. 144.
    Kurosaki M, Enomoto N, Sato C, Sakamoto N, Hoshino Y, Haritani H, Marumo F. Correlation of plasma hepatitis C virus RNA levels with serum alanine aminotransferase in non-A, non-B chronic liver disease. J Med Virol 1993; 39:246.PubMedCrossRefGoogle Scholar
  145. 145.
    Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K. Ishikawa T, Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994; 39:234.PubMedCrossRefGoogle Scholar
  146. 146.
    McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 1996; 23:676.PubMedCrossRefGoogle Scholar
  147. 147.
    Zeuzem S, Franke A, Lee J-H, Herrman G, Rüster B, Roth WK. Phy logenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996; 24:1003.PubMedCrossRefGoogle Scholar
  148. 148.
    Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25:211.PubMedCrossRefGoogle Scholar
  149. 149.
    Zhou S, Ferrault NA, Ferrell L, Hahn JA, Lau JYN, Simmonds P, Roberts JP, Lake JR, Ascher NL. Wright TL. Seventy of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24:1041.PubMedCrossRefGoogle Scholar
  150. 150.
    Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology 1997; 25:697.PubMedCrossRefGoogle Scholar
  151. 151.
    Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89:3468.PubMedCrossRefGoogle Scholar
  152. 152.
    Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68: 1494.PubMedGoogle Scholar
  153. 153.
    Takada N, Matsuda Y, Takase S, Takada A, Date T. New genotypes of hepatitis C virus. Gastroenterol Jpn 1993: 28: 323.PubMedGoogle Scholar
  154. 154.
    Zein NN, Poterucha JJ, Gross JB Jr, Wiesner RH, Therneau TM, Gossard AA, Wendt NK, Mitchell S, Germer JJ, Persing DH. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. Am J Gastroenterol 1996; 91:2560.PubMedGoogle Scholar
  155. 155.
    Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, Asti M, Rossi S, Larghi A Cerino A, Podda M, Mondelli MU. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25:754.PubMedCrossRefGoogle Scholar
  156. 156.
    Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta. Hepatology 1993; 18: 1319.PubMedGoogle Scholar
  157. 157.
    Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizawa H, Okamoto H. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA (letter). Dig Dis Sci 1994; 39: 441.PubMedCrossRefGoogle Scholar
  158. 158.
    Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon (letter). Lancet 1992; 339:1543.PubMedCrossRefGoogle Scholar
  159. 159.
    Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 1992; 16:619.PubMedCrossRefGoogle Scholar
  160. 160.
    Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16:293.PubMedCrossRefGoogle Scholar
  161. 161.
    Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology 1997; 25: 1250.PubMedCrossRefGoogle Scholar
  162. 162.
    Shindo M, Hamada K, Koya S, Arai K, Sokawa Y, Okundo T. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 1996; 24: 1018.PubMedCrossRefGoogle Scholar
  163. 163.
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus lb. Sensitivity to interferon is conferred by amino acid substitutions in theNS5A region. J Clin Invest 1995; 96:224.PubMedCrossRefGoogle Scholar
  164. 164.
    Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al. Mutations in the nonstructural protein5A gene and response to interferon in patients with chronic hepatitis C virus lb infection. N Engl J Med 1996; 334:77.PubMedCrossRefGoogle Scholar
  165. 165.
    Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. Analysis of genotypes and amino acid residues 2209 to 2248 of theNS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 1997; 25: 750.PubMedCrossRefGoogle Scholar
  166. 166.
    Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K. Kumada H. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype lb hepatitis C virus infection. Hepatology 1997; 25:745.PubMedCrossRefGoogle Scholar
  167. 167.
    Zeuzem S, Lee JH, Roth WK. Mutations in the nonstructural5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 1997; 25:740.PubMedCrossRefGoogle Scholar
  168. 168.
    Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, Lampis R, Cao A, Lai ME, Virgilis S de. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996; 24: 1338.PubMedCrossRefGoogle Scholar
  169. 169.
    Tibbs C, Donaldson P, UnderhilÏ J, Thomson L, Manabe K, Williams R. Evidence that the HLA DQAl *03 allele confers protection from chronic HCV-infection in northern European Caucasoids. Hepatology 1996; 24: 1342.PubMedCrossRefGoogle Scholar
  170. 170.
    Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825.PubMedCrossRefGoogle Scholar
  171. 171.
    Roudot-Thoraval F, Bastie A, Pawlotsky J-M, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. Hepatology 1997; 26:485.PubMedCrossRefGoogle Scholar
  172. 172.
    Ohno T, Lau JYN. The “gold-standard”, accuracy, and the current concepts: hepatitis C virus genotype and viremia. Hepatology 1996: 24:1312.PubMedGoogle Scholar
  173. 173.
    Dienstag JL. The natural history of chronic hepatitis C and what we should do about it. Gastroenterology 1997; 112:651.PubMedCrossRefGoogle Scholar
  174. 174.
    Lai MM, Lee CM, Bih FY, Govindarajan S. The molecular basis of heterogeneity of hepatitis delta virus. J Hepatol 1991;13 [Suppl4]:S121.PubMedCrossRefGoogle Scholar
  175. 175.
    Taylor JM. Human hepatitis delta virus. Curr Top Microbiol Immunol 1991; 168:141.PubMedGoogle Scholar
  176. 176.
    Makino S, Chang MF, Shieh CK, Kamahora T, Vannier DM. Govindarajan S, Lai MM. Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature 1987; 329:343.PubMedCrossRefGoogle Scholar
  177. 177.
    Saldanha JA, Thomas HC, Monjardino JP. Cloning and sequencing of RNA of hepatitis delta virus isolated from human serum. J Gen Virol 1990; 71: 1603.PubMedGoogle Scholar
  178. 178.
    Imazeki F, Omata M, Ohto M. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 1990; 64:5594.PubMedGoogle Scholar
  179. 179.
    Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 1993; 90: 9016.PubMedCrossRefGoogle Scholar
  180. 180.
    Lee CM, Bih FY, Chao YC, Govindarajan S, Lai MM. Evolution of hepatitis delta virus RNA during chronic infection. Virology 1992;188:265.PubMedCrossRefGoogle Scholar
  181. 181.
    Wu JC, Choo KB, Chen CM Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 1995; 346:939.PubMedCrossRefGoogle Scholar
  182. 182.
    Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 1997; 25:728.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • H. E. Blum
    • 1
  1. 1.Department of Internal Medicine IIUniversity of FreiburgFreiburgGermany

Personalised recommendations